Fatal bleedings with prasugrel as part of triple antithrombotic therapy.
Division of Cardiolgy, IRCCS Arcispedale S. Maria Nuova, Reggio Emilia, Italy. Electronic address: stefano.savonitto@asmn.re.it.
Stefano
S
Savonitto
Division of Cardiolgy, IRCCS Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
Marco
M
Ferri
Cardiovascular Department, Humanitas Clinical and Research Center, Rozzano, Italy.
Elena
E
Corrada
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000009:adverse effects*; D001165:Arteriovenous Malformations / Q000473:pathology; D001241:Aspirin / Q000009:adverse effects; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D000068799:Prasugrel Hydrochloride; D015607:Stents / Q000009:adverse effects; D013876:Thiophenes / Q000009:adverse effects*; D013927:Thrombosis / Q000188:drug therapy; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D014859:Warfarin; D000068799:Prasugrel Hydrochloride; D001241:Aspirin